Summary
President Trump plans to nominate Heidi Overton to be the next leader of the Food and Drug Administration (FDA). The agency has faced challenges after the previous commissioner left earlier this year.Key Facts
- Heidi Overton is currently a deputy director at the White House Domestic Policy Council.
- The FDA has been unsettled since Marty Makary left as commissioner.
- Overton was one of several candidates considered for the role.
- President Trump’s choice was first reported by Bloomberg.
- Overton recently participated in signing an order about changing the childhood vaccine schedule.
- The executive order aims to reduce the number of recommended vaccines and separate the MMR vaccine into three shots.
- The FDA plays a key role in regulating drug development in the U.S.
